Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,243 Jan 1 – Oct 28, 2026
- Disclosed funding
- $257.3B 1862 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| W WaferCompany profile Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes. Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes. | $40M | Series A | Hardware | United States | Investors | |
| HR Hi RasmusCompany profile Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families. Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families. | $50M | Strategic minority investmentUndisclosed | Healthtech | United States | Investors | |
Medici BrandsCompany profile Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. | $250M | Series B | Foodtech | United States | Investors | |
CapacityCompany profile Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform. Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform. | >$54M | Series ESeries C+ | Enterprise software | United States | Investors | |
BQPCompany profile A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems. A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems. | Undisclosed | Strategic investmentUndisclosed | AI | United States | Investors | |
Konko AICompany profile Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. | $6M | FundingUndisclosed | Healthtech | United States | Investors | |
N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
ArchiveCompany profile A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. | Undisclosed | Growth investmentGrowth | Media & gaming | United States | Investors | |
NewlightCompany profile Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. | $9M | Seed | Climate tech | United States | Investors | |
| TT Typewriter TherapeuticsCompany profile Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. | $56M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
133rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
73rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Sequoia Capital
Hex, Warhound, Whop
58rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.